Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study
Saved in:
| Published in: | Hepatic Medicine: Evidence and Research |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301672789737472 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Hepatic Medicine: Evidence and Research |
| description | |
| discipline_display | Gastroenterology and Hepatology |
| discipline_facet | Gastroenterology and Hepatology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:71221 |
| institution | FRELIP |
| journal_source_facet | Hepatic Medicine: Evidence and Research |
| publishDate | 2025 |
| publishDateSort | 2025 |
| record_format | rss_article |
| spellingShingle | The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study Gastroenterology and Hepatology General Gastroenterology and Hepatology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Gastroenterology and Hepatology General Gastroenterology and Hepatology Gastroenterology and Hepatology General Gastroenterology and Hepatology |
| subject_facet | Gastroenterology and Hepatology General Gastroenterology and Hepatology |
| title | The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study |
| title_auth | The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study |
| title_full | The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study |
| title_fullStr | The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study |
| title_full_unstemmed | The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study |
| title_short | The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study |
| title_sort | the effect of liv.52 ds in metabolic dysfunction-associated fatty liver disease (mafld): a pilot, randomized, double-blind, placebo-controlled, clinical study |
| topic | Gastroenterology and Hepatology General Gastroenterology and Hepatology |
| url | https://www.dovepress.com/the-effect-of-liv52-ds-in-metabolic-dysfunction-associated-fatty-liver-peer-reviewed-fulltext-article-HMER |